Aktive Positionen von Stefan Degenhardt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Vorstandsvorsitzender | 01.05.2018 | - |
Karriereverlauf von Stefan Degenhardt
Ehemalige bekannte Positionen von Stefan Degenhardt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Pierrel Research Onco-Immunology GmbH | Verwaltungsdirektor | - | - |
| Finanzdirektor/CFO | - | - | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Finanzdirektor/CFO | 01.10.2011 | - |
Statistik
International
| Deutschland | 4 |
Operativ
| Director of Finance/CFO | 2 |
| Chief Administrative Officer | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
| Pierrel Research Onco-Immunology GmbH | |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Health Technology |
- Börse
- Insiders
- Stefan Degenhardt
- Erfahrung